FC
ORGO icon

Financial Consulate’s Organogenesis Holdings ORGO Stock Holding History

Financial Consulate’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60
Closed -$254 – 1417
2025
Q3 		$254 Buy
+60
New +$279 ﹤0.01% 1127

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Consulate's ORGO Position: Q4 2025 in Review

Financial Consulate sold out of Organogenesis Holdings (ORGO) in Q4 2025, closing a stake of 60 shares — an estimated $254 sold.

Financial Consulate first reported a position in ORGO in Q3 2025 and held it in 1 quarter. The position peaked at $254 in Q3 2025. 147 funds tracked by Wall St. Rank hold ORGO as of Q4 2025.

  • Financial Consulate reported no remaining Organogenesis Holdings position as of Q4 2025 after selling out during the quarter.
  • Financial Consulate sold 60 Organogenesis Holdings shares in Q4 2025, an estimated $254.
  • Financial Consulate first reported a position in Organogenesis Holdings in Q3 2025 and held it in 1 quarter.
  • Financial Consulate's Organogenesis Holdings position peaked at $254 in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2025.

Based on Financial Consulate's 13F filing for Q4 2025, filed 22 Jan 2026.